Flagellin or Lipopolysaccharide Treatment Modified Macrophage Populations after Colorectal Radiation of Rats
Authors:
- 1 July 2013
- journal article
- research article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 346 (1) , 75-85
Abstract
Radiation-induced acute intestinal toxicity remains a major limitation to the delivery of tumoricidal doses of colorectal irradiation. Recent reports indicate that Toll-like receptor (TLR) agonists TLR4 and TLR5 protect against toxicity due to intestinal irradiation. The phenotype (M1 or M2) of macrophages expressing TLRs may play a role in tissue repair. The aim was to investigate whether administration of TLR4 agonist lipopolysaccharide (LPS) or TLR5 agonist flagellin after irradiation modified the recruitment and phenotype of colonic macrophages and improved tissue damage. Rats were exposed to single 20- or 27-Gy doses of colorectal irradiation. TLR4 agonist LPS or TLR5 agonist flagellin (at 50 or 200 µ g/rat) was administered i.p. 3 days after irradiation. Flow cytometric analysis, immunostaining, and real-time polymerase chain reaction analysis were used to assess the M1/M2 phenotype and crypt cell proliferation 7 days after irradiation. Irradiation (20 and 27 Gy) increased TLR4+ and TLR5+ macrophage frequency in the mucosa. LPS or flagellin administration maintained this elevated frequency after the 27-Gy irradiation. LPS and flagellin drove macrophages toward the anti-inflammatory M2 phenotype by increasing Arg1 and CD163 expression and microenvironmental effector molecules (C-C motif chemokine 22, transforming growth factor- β 1, and interleukin-10). Proliferating cell nuclear antigen immunostaining, Ki67 expression, and antimicrobial factor Reg3 γ showed that the M2 shift correlated with epithelial regeneration. In conclusion, administration of either LPS or flagellin after colorectal irradiation may provide effective protection against epithelial remodeling. This tissue repair was associated with an M2 macrophage shift. Using TLR agonists to moderately activate innate immunity should be considered as a strategy for protecting healthy tissue from irradiation.Keywords
This publication has 36 references indexed in Scilit:
- PAI-1-Dependent Endothelial Cell Death Determines Severity of Radiation-Induced Intestinal InjuryPLOS ONE, 2012
- The phenotype of murine wound macrophagesJournal of Leukocyte Biology, 2009
- Endotoxin tolerance: new mechanisms, molecules and clinical significanceTrends in Immunology, 2009
- Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular componentBiomaterials, 2009
- An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate ModelsScience, 2008
- Expression of Toll-like Receptor 2 (TLR2), TLR4, and CD14 in Biopsy Samples of Patients With Inflammatory Bowel Diseases: Upregulated Expression of TLR2 in Terminal Ileum of Patients With Ulcerative ColitisJournal of Histochemistry & Cytochemistry, 2007
- TLR4 agonists as immunomodulatory agentsInnate Immunity, 2006
- Significance of plasma transforming growth factor-β levels in radiotherapy for non–small-cell lung cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Intestinal Epithelial Toll-Like Receptors: To Protect. And Serve?Current Pharmaceutical Design, 2003
- Alternative activation of macrophagesNature Reviews Immunology, 2003